Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.
Saved in:
| Title: | Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records. |
|---|---|
| Authors: | Villanueva V; Refractory Epilepsy Unit, Hospital Universitario y Politécnico La Fe, EpiCARE member, Avenida Fernando Abril Martorell 106, 46026, Valencia, Spain. villanueva_vichab@gva.es., Laloyaux C; UCB Pharma, Brussels, Belgium., D'Souza W; Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Melbourne, Australia., Faught E; Emory Epilepsy Center, Atlanta, GA, USA., Klein P; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA., Reuber M; The University of Sheffield, Sheffield, UK., Rosenow F; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, Center of Neurology and Neurosurgery, Frankfurt am Main, Germany., Salas-Puig J; Universitari Vall d'Hebron, Barcelona, Spain., Insuga VS; Pediatric Neurology, Hospital Universitario Infantil Niño Jesús, Madrid, Spain., Strzelczyk A; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, Center of Neurology and Neurosurgery, Frankfurt am Main, Germany., Szaflarski JP; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Department of Neurology and UAB Epilepsy Center, Birmingham, AL, USA., Chinn C; UCB Pharma, Slough, England, UK., Daniels T; UCB Pharma, Morrisville, NC, USA., Floricel F; UCB Pharma, Monheim am Rhein, Germany., Friesen D; UCB Pharma, Slough, England, UK., Sendersky V; UCB Pharma, Brussels, Belgium., Besson H; UCB Pharma, Breda, The Netherlands., Steinhoff BJ; Kork Epilepsy Center, Kehl-Kork and Medical Faculty, University of Freiburg, Freiburg, Germany. |
| Source: | CNS drugs [CNS Drugs] 2023 Sep; Vol. 37 (9), pp. 819-835. Date of Electronic Publication: 2023 Sep 09. |
| Publication Type: | Review; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37684497 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Villanueva+V%22">Villanueva V</searchLink>; Refractory Epilepsy Unit, Hospital Universitario y Politécnico La Fe, EpiCARE member, Avenida Fernando Abril Martorell 106, 46026, Valencia, Spain. villanueva&#95;vichab@gva.es.<br /><searchLink fieldCode="AU" term="%22Laloyaux+C%22">Laloyaux C</searchLink>; UCB Pharma, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22D'Souza+W%22">D'Souza W</searchLink>; Department of Medicine, St Vincent's Hospital Melbourne, The University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Faught+E%22">Faught E</searchLink>; Emory Epilepsy Center, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Klein+P%22">Klein P</searchLink>; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Reuber+M%22">Reuber M</searchLink>; The University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Rosenow+F%22">Rosenow F</searchLink>; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, Center of Neurology and Neurosurgery, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Salas-Puig+J%22">Salas-Puig J</searchLink>; Universitari Vall d'Hebron, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Insuga+VS%22">Insuga VS</searchLink>; Pediatric Neurology, Hospital Universitario Infantil Niño Jesús, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Strzelczyk+A%22">Strzelczyk A</searchLink>; Epilepsy Center Frankfurt Rhine-Main and Department of Neurology, Center of Neurology and Neurosurgery, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Szaflarski+JP%22">Szaflarski JP</searchLink>; University of Alabama at Birmingham (UAB) Heersink School of Medicine, Department of Neurology and UAB Epilepsy Center, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Chinn+C%22">Chinn C</searchLink>; UCB Pharma, Slough, England, UK.<br /><searchLink fieldCode="AU" term="%22Daniels+T%22">Daniels T</searchLink>; UCB Pharma, Morrisville, NC, USA.<br /><searchLink fieldCode="AU" term="%22Floricel+F%22">Floricel F</searchLink>; UCB Pharma, Monheim am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Friesen+D%22">Friesen D</searchLink>; UCB Pharma, Slough, England, UK.<br /><searchLink fieldCode="AU" term="%22Sendersky+V%22">Sendersky V</searchLink>; UCB Pharma, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Besson+H%22">Besson H</searchLink>; UCB Pharma, Breda, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Steinhoff+BJ%22">Steinhoff BJ</searchLink>; Kork Epilepsy Center, Kehl-Kork and Medical Faculty, University of Freiburg, Freiburg, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229431220%22">CNS drugs</searchLink> [CNS Drugs] 2023 Sep; Vol. 37 (9), pp. 819-835. <i>Date of Electronic Publication: </i>2023 Sep 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Review; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9431220 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1934 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211727047%22">11727047 </searchLink><i>NLM ISO Abbreviation: </i>CNS Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37684497 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40263-023-01033-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 819 Titles: – TitleFull: Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Villanueva V – PersonEntity: Name: NameFull: Laloyaux C – PersonEntity: Name: NameFull: D'Souza W – PersonEntity: Name: NameFull: Faught E – PersonEntity: Name: NameFull: Klein P – PersonEntity: Name: NameFull: Reuber M – PersonEntity: Name: NameFull: Rosenow F – PersonEntity: Name: NameFull: Salas-Puig J – PersonEntity: Name: NameFull: Insuga VS – PersonEntity: Name: NameFull: Strzelczyk A – PersonEntity: Name: NameFull: Szaflarski JP – PersonEntity: Name: NameFull: Chinn C – PersonEntity: Name: NameFull: Daniels T – PersonEntity: Name: NameFull: Floricel F – PersonEntity: Name: NameFull: Friesen D – PersonEntity: Name: NameFull: Sendersky V – PersonEntity: Name: NameFull: Besson H – PersonEntity: Name: NameFull: Steinhoff BJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2023 Sep Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1179-1934 Numbering: – Type: volume Value: 37 – Type: issue Value: 9 Titles: – TitleFull: CNS drugs Type: main |
| ResultId | 1 |